Bank of New York Mellon’s Protara Therapeutics TARA Stock Holding History

Bank of New York Mellon’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$526K	Buy	137,689 +8,018	+6%	+$38.1K	﹤0.01%	3729
2026 Q1	$676K	Buy	129,671 +36,149	+39%	+$214K	﹤0.01%	3447
2025 Q4	$498K	Sell	93,522 -3,471	-4%	-$19.3K	﹤0.01%	3617
2025 Q3	$422K	Buy	96,993 +2,876	+3%	+$9.31K	﹤0.01%	3687
2025 Q2	$285K	Buy	94,117 +75,767	+413%	+$261K	﹤0.01%	3830
2025 Q1	$78.2K	Buy	18,350 +2,467	+16%	+$11K	﹤0.01%	4028
2024 Q4	$83.9K	Sell	15,883 -2,024	-11%	-$6.54K	﹤0.01%	4045
2024 Q3	$32.8K	Hold	17,907	–	–	﹤0.01%	4059
2024 Q2	$37.2K	Hold	17,907	–	–	﹤0.01%	4067
2024 Q1	$71.8K	Hold	17,907	–	–	﹤0.01%	4060
2023 Q4	$33.6K	Hold	17,907	–	–	﹤0.01%	4193
2023 Q3	$29.9K	Hold	17,907	–	–	﹤0.01%	4218
2023 Q2	$42.8K	Hold	17,907	–	–	﹤0.01%	4200
2023 Q1	$56K	Hold	17,907	–	–	﹤0.01%	4173
2022 Q4	$48K	Hold	17,907	–	–	﹤0.01%	4245
2022 Q3	$53K	Hold	17,907	–	–	﹤0.01%	4312
2022 Q2	$53K	Hold	17,907	–	–	﹤0.01%	4335
2022 Q1	$92K	Hold	17,907	–	–	﹤0.01%	4421
2021 Q4	$120K	Hold	17,907	–	–	﹤0.01%	4379
2021 Q3	$124K	Hold	17,907	–	–	﹤0.01%	4290
2021 Q2	$174K	Sell	17,907 -7,778	-30%	-$88.1K	﹤0.01%	4128
2021 Q1	$404K	Buy	25,685 +543	+2%	+$10.1K	﹤0.01%	3803
2020 Q4	$608K	Buy	+25,142	New	+$542K	﹤0.01%	3517
2016 Q2	–	Sell	-493	Closed	-$152K	–	4352
2016 Q1	$152K	Hold	493	–	–	﹤0.01%	3863
2015 Q4	$306K	Hold	493	–	–	﹤0.01%	3718
2015 Q3	$274K	Sell	493 -44	-8%	-$27.2K	﹤0.01%	3803
2015 Q2	$383K	Buy	+537	New	+$332K	﹤0.01%	3714

Other funds holding TARA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon's TARA Position: Q2 2026 in Review

Bank of New York Mellon increased its Protara Therapeutics (TARA) stake by 6.2% in Q2 2026, buying an estimated $38.1K and bringing the position to 137,689 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #3729.

Bank of New York Mellon first reported a position in TARA in Q2 2015 and has held it in 27 quarters since. The position peaked at $676K in Q1 2026. 42 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

Bank of New York Mellon held 137,689 shares of Protara Therapeutics worth $526K as of Q2 2026.
Bank of New York Mellon bought 8,018 Protara Therapeutics shares in Q2 2026, an estimated $38.1K.
Protara Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3729 holding.
Bank of New York Mellon first reported a position in Protara Therapeutics in Q2 2015 and has held it in 27 quarters since.
Bank of New York Mellon's Protara Therapeutics position peaked at $676K in Q1 2026.
42 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.